Atropine, Ondansetron, and Ketorolac: Supplemental Management of Amniotic Fluid Embolism

Conclusion: Management of AFE should include consideration of the addition of AOK to typical guidelines.PMID:36189093 | PMC:PMC9477128 | DOI:10.31486/toj.21.0107

Source: Ochsner Journal - October 3, 2022 Category: General Medicine Authors: Miranda Long Jane Martin Joseph Biggio Source Type: research